Evidence map›Paper›PMID 39051589›Full record

ArticleInternational journal of surgical pathology2025

Uterine Angioleiomyoma: Clinical and Histopathologic Differentiation of an Underrecognized Mimicker of Uterine Leiomyoma.

Tuan Pham, Joshua M Peterson, Hasanain Hasan, Mariangela Gomez

Abstract readCase Reports
In one paragraph

Article in International journal of surgical pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tuan PhamJohn Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX, USA.ORCID 0009-0001-3073-9960
Joshua M PetersonDepartment of Pathology, University of Texas Medical Branch, Galveston, TX, USA.ORCID 0000-0001-7620-0584
Hasanain HasanDepartment of Pathology, University of Texas Medical Branch, Galveston, TX, USA.ORCID 0009-0004-1345-0649
Mariangela GomezDepartment of Pathology, University of Texas Medical Branch, Galveston, TX, USA.ORCID 0000-0003-0331-1536

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angioleiomyoma is an uncommon benign neoplasm of mesenchymal origin that arises from perivascular smooth muscle cells. This soft tissue neoplasm usually occurs in the dermal or subcutaneous tissues of the extremities, head and neck, or trunk with fewer than 40 reported angioleiomyomas arising in the uterine corpus. Herein we report a uterine angioleiomyoma in a 44-year-old G5P4 Hispanic woman with a longstanding history of recurrent abdominal pain, pelvic organ prolapse, abnormal uterine bleeding, anemia, and hypertension. The patient underwent surgical treatment with total laparoscopic hysterectomy with bilateral salpingectomy and a uterosacral ligament suspension. Uterine angioleiomyoma was diagnosed post-operatively based on gross and microscopic features. The location of the uterine angioleiomyoma within the myometrium corresponded with contrast enhancement apparent on preoperative imaging. This and other uterine angioleiomyomas have characteristic imaging, macroscopic, and microscopic features which distinguish it from leiomyoma. Enhancing awareness of this underrecognized entity will facilitate precise diagnosis and thereby enable improved understanding of the clinicopathological characteristics of uterine angioleiomyoma.

Indexed as

AngiomyomaLeiomyomaUterine NeoplasmsAdultDiagnosis, DifferentialFemaleHumansHysterectomyUterusabnormal uterine bleedingangioleiomyomafibroidleiomyomaleiomyoma variantsmyometriummyopericytomaPEComauterine angioleiomyoma

Identifiers

PMID39051589
PMCPMC11915755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.